India's first dengue vaccine approved India's drug regulatory authority has approved the Kydenga vaccine against dengue for use. The dengue vaccine has been approved in India. The vaccine named Kydenga, developed by a Japanese company against the dengue virus, has been approved for use in India. Developed by Japanese pharmaceutical company Takeda Pharmaceuticals , this vaccine has been approved by India's drug regulatory authority Central Drug Standards and Organization (CDACO). The Kydenga vaccine is said to provide protection against all four types of dengue virus serotypes 1, 2, 3 and 4 . Like the COVID-19 vaccine , it requires two doses. The second dose should be given three months after the first dose. This vaccine, which can be given to people aged 4 to 60 years, can also be given to those who have not had dengue. This vaccine, which is currently being produced in India, currently costs between Rs 6,000 and Rs 12,000 per dose . The price is expected to come down in ...
Is it known during pregnancy that the child has autism? Raising children is the biggest responsibility of parents. If the child has a specific disorder or disease, the responsibility of the parents increases even more. It can be challenging for parents who care for children with autism spectrum disorder. Autism is a brain disease, which occurs mostly in children, and is very difficult to diagnose. Autism symptoms are not detected until the child is one or two years old. This disease can be detected only by the child's behavior, unusual reactions and gestures. If your child is quieter than other children or slow to react to anything, these signs may be of autism. It is a developmental disorder in which affected individuals have difficulty speaking, reading, writing, and socializing. Autism is a condition in which the brain of a person suffering from it works differently from the brain of other people. At the same time, people suffering from autism are also different from each other....